127 related articles for article (PubMed ID: 23040504)
1. Genomic stability in reprogramming.
Ronen D; Benvenisty N
Curr Opin Genet Dev; 2012 Oct; 22(5):444-9. PubMed ID: 23040504
[TBL] [Abstract][Full Text] [Related]
2. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.
Pan G; Wang T; Yao H; Pei D
Bioessays; 2012 Jun; 34(6):472-6. PubMed ID: 22419173
[TBL] [Abstract][Full Text] [Related]
3. Telomere rejuvenation during nuclear reprogramming.
Marión RM; Blasco MA
Curr Opin Genet Dev; 2010 Apr; 20(2):190-6. PubMed ID: 20176474
[TBL] [Abstract][Full Text] [Related]
4. Advances in cell lineage reprogramming.
Zhou J; Yue W; Pei X
Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
[TBL] [Abstract][Full Text] [Related]
5. Human induced pluripotent stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell-like metabolic reprogramming.
Prigione A; Lichtner B; Kuhl H; Struys EA; Wamelink M; Lehrach H; Ralser M; Timmermann B; Adjaye J
Stem Cells; 2011 Sep; 29(9):1338-48. PubMed ID: 21732474
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming of somatic cells.
Rajasingh J
Prog Mol Biol Transl Sci; 2012; 111():51-82. PubMed ID: 22917226
[TBL] [Abstract][Full Text] [Related]
7. Comparison of reprogramming ability of mouse ES and iPS cells measured by somatic cell fusion.
Sumer H; Nicholls C; Liu J; Tat PA; Liu JP; Verma PJ
Int J Dev Biol; 2010; 54(11-12):1723-8. PubMed ID: 21404192
[TBL] [Abstract][Full Text] [Related]
8. Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells.
Pick M; Stelzer Y; Bar-Nur O; Mayshar Y; Eden A; Benvenisty N
Stem Cells; 2009 Nov; 27(11):2686-90. PubMed ID: 19711451
[TBL] [Abstract][Full Text] [Related]
9. Induced pluripotent stem cells: an emerging theranostics platform.
Nelson TJ; Terzic A
Clin Pharmacol Ther; 2011 May; 89(5):648-50. PubMed ID: 21512525
[TBL] [Abstract][Full Text] [Related]
10. Ataxia-telangiectasia mutated (ATM) deficiency decreases reprogramming efficiency and leads to genomic instability in iPS cells.
Kinoshita T; Nagamatsu G; Kosaka T; Takubo K; Hotta A; Ellis J; Suda T
Biochem Biophys Res Commun; 2011 Apr; 407(2):321-6. PubMed ID: 21385566
[TBL] [Abstract][Full Text] [Related]
11. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
Anastasia L; Pelissero G; Venerando B; Tettamanti G
Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332
[TBL] [Abstract][Full Text] [Related]
12. Prospects of induced pluripotent stem cell technology in regenerative medicine.
Zhang F; Citra F; Wang DA
Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
[TBL] [Abstract][Full Text] [Related]
13. iPSC lines that do not silence the expression of the ectopic reprogramming factors may display enhanced propensity to genomic instability.
Ramos-Mejia V; Muñoz-Lopez M; Garcia-Perez JL; Menendez P
Cell Res; 2010 Oct; 20(10):1092-5. PubMed ID: 20820191
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming to iPS cells and their subsequent hematopoietic differentiation is more efficient from MEFs than from preB cells.
Reimer A; Seiler K; Tornack J; Tsuneto M; Melchers F
Immunol Lett; 2012 Mar; 143(1):70-6. PubMed ID: 22313949
[TBL] [Abstract][Full Text] [Related]
15. [Genetic manipulation and studying of differentiation properties of rat induced pluripotent stem cells].
Liskovykh MA; Chuĭkin IA; Ranjan A; Popova E; Tolkunova EN; Chechik LL; Malinin AIu; Morozova AV; Mosienko V; Bader M; alenina N; Tomilin AN
Tsitologiia; 2011; 53(12):946-51. PubMed ID: 22359953
[TBL] [Abstract][Full Text] [Related]
16. Cell fate plug and play: direct reprogramming and induced pluripotency.
Chambers SM; Studer L
Cell; 2011 Jun; 145(6):827-30. PubMed ID: 21663788
[TBL] [Abstract][Full Text] [Related]
17. Single transcription factor reprogramming of hair follicle dermal papilla cells to induced pluripotent stem cells.
Tsai SY; Bouwman BA; Ang YS; Kim SJ; Lee DF; Lemischka IR; Rendl M
Stem Cells; 2011 Jun; 29(6):964-71. PubMed ID: 21563278
[TBL] [Abstract][Full Text] [Related]
18. A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation.
Li Y; Geng YJ
Growth Horm IGF Res; 2010 Dec; 20(6):391-8. PubMed ID: 20956084
[TBL] [Abstract][Full Text] [Related]
19. p53 isoform Δ133p53 promotes efficiency of induced pluripotent stem cells and ensures genomic integrity during reprogramming.
Gong L; Pan X; Chen H; Rao L; Zeng Y; Hang H; Peng J; Xiao L; Chen J
Sci Rep; 2016 Nov; 6():37281. PubMed ID: 27874035
[TBL] [Abstract][Full Text] [Related]
20. Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.
Muenthaisong S; Ujhelly O; Polgar Z; Varga E; Ivics Z; Pirity MK; Dinnyes A
Exp Cell Res; 2012 Nov; 318(19):2482-9. PubMed ID: 22846649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
